|
77
|
310
|
5iycM |
Human core-pic in the initial transcribing state |
|
79
|
310
|
5iy9M |
Human holo-pic in the initial transcribing state (no iis) |
|
83
|
310
|
5iy7M |
Human holo-pic in the open state |
|
37
|
106
|
6j3oA |
Crystal structure of the human pcaf bromodomain in complex with compound 12 |
|
38
|
108
|
6j3pA |
Crystal structure of the human gcn5 bromodomain in complex with compound (r,r)-36n |
|
75
|
292
|
5j9qA |
Crystal structure of the nua4 core complex |
|
43
|
117
|
3svhA |
Crystal structure of the bromdomain of human crebbp in complex with a 3,5-dimethylisoxazol ligand |
|
2
|
10
|
3s9sB |
Ligand binding domain of ppargamma complexed with a benzimidazole partial agonist |
|
164
|
588
|
6gyrA |
Transcription factor dimerization activates the p300 acetyltransferase |
|
2
|
10
|
6a5yB |
Crystal structure of human fxr/rxr-lbd heterodimer bound to hnc143 and 9cra and src1 |
|
2
|
12
|
6a5wB |
Fxr-lbd with hnc143 and src1 |
|
13
|
39
|
5vjxB |
Crystal structure of the clock transcription domain exon19 in complex with a repressor |
|
3
|
13
|
5q0vB |
Ligand binding to farnesoid-x-receptor |
|
2
|
10
|
5q10B |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q0lB |
Ligand binding to farnesoid-x-receptor |
|
2
|
11
|
5q0sB |
Ligand binding to farnesoid-x-receptor |
|
2
|
11
|
5q19B |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q0nB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q14B |
Ligand binding to farnesoid-x-receptor |
|
4
|
13
|
5q0kB |
Ligand binding to farnesoid-x-receptor |
|
2
|
10
|
5mwpB |
The structure of mr in complex with azd9977. |
|
2
|
10
|
5mwyB |
The structure of mr in complex with eplerenone. |
|
37
|
114
|
5mqeA |
Crystal structure of crebbp bromodomain complexed with cbp006 |
|
57
|
137
|
5mg2A |
Crystal structure of the second bromodomain of human taf1 in complex with bay-299 chemical probe |
|
39
|
117
|
5mqkA |
Crystal structure of crebbp bromodomain complexed with cbp019 |
|
39
|
109
|
5mljA |
Bromodomain of human gcn5 with 4-bromo-2-methyl-5-(((3r,5r)-1-methyl-5-phenylpiperidin-3-yl)amino)pyridazin-3(2h)-one |
|
43
|
116
|
5mqgA |
Crystal structure of crebbp bromodomain complexed with cbp015 |
|
39
|
118
|
5mpnA |
Crystal structure of crebbp bromodomain complexed with fa26 |
|
38
|
110
|
5mpzA |
Crystal structure of crebbp bromodomain complexed with cbp007 |
|
44
|
115
|
5mmgA |
Crystal structure of crebbp bromodomain complexed with ut07c |
|
39
|
108
|
5ml0A |
Bromodomain of mouse pcaf with (r)-4-chloro-2-methyl-5-((1-methylpiperidin-3-yl)amino)pyridazin-3(2h)-one |
|
41
|
112
|
5mpkA |
Crystal structure of crebbp bromodomain complexed with dk19 |
|
41
|
106
|
5mkxA |
1.68a structure pcaf bromodomain with 4-chloro-2-methyl-5-(methylamino)pyridazin-3(2h)-one |
|
173
|
561
|
5lktA |
Crystal structure of the p300 acetyltransferase catalytic core with butyryl-coenzyme a. |
|
38
|
108
|
5lvqA |
Crystal structure of human pcaf bromodomain in complex with compound-d (cpd-d), n-methyl-2-(tetrahydro-2h-pyran-4-yloxy)benzamide |
|
41
|
108
|
5lvrA |
Crystal structure of human pcaf bromodomain in complex with compound-e (cpd-e) |
|
41
|
116
|
5lpkA |
Crystal structure of the bromodomain of human ep300 bound to the inhibitor xdm1 |
|
164
|
561
|
5lkzA |
Crystal structure of the p300 acetyltransferase catalytic core with crotonyl-coenzyme a. |
|
2
|
10
|
5l7hB |
Mcr in complex with ligand |
|
39
|
116
|
5lpmA |
Crystal structure of the bromodomain of human ep300 bound to the inhibitor xdm3d |
|
166
|
558
|
5lkuA |
Crystal structure of the p300 acetyltransferase catalytic core with coenzyme a. |
|
170
|
560
|
5lkxA |
Crystal structure of the p300 acetyltransferase catalytic core with propionyl-coenzyme a. |
|
2
|
10
|
5l7eB |
Mcr in complex with ligand |
|
42
|
114
|
5ktxA |
Crebbp bromodomain in complex with cpd59 ((s)-1-(3-((2-fluoro-4-(1-methyl-1h-pyrazol-4-yl)phenyl)amino)-1-(tetrahydrofuran-3-yl)-6,7-dihydro-1h-pyrazolo[4,3-c]pyridin-5(4h)-yl)ethanone) |
|
37
|
114
|
5ktwA |
Crebbp bromodomain in complex with cpd 44 (3-((5-acetyl-1-(cyclopropylmethyl)-4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridin-3-yl)amino)-n-isopropylbenzamide) |
|
83
|
278
|
5j9tA |
Crystal structure of the nua4 core complex |
|
110
|
343
|
5kj2A |
The novel p300/cbp inhibitor a-485 uncovers a unique mechanism of action to target ar in castrate resistant prostate cancer |
|
77
|
292
|
5j9uA |
Crystal structure of the nua4 core complex |
|
4
|
19
|
5ji0E |
Ppargamma-rxralpha(s427f) heterodimer in complex with src-1, rosiglitazone, and 9-cis-retanoic acid |
|
70
|
272
|
5j8fA |
Human mof k274p crystal structure |
